Market Place
Sourcing Support
Antengene`s Xpovio® Approved For Third Indication In South Korea
17 Oct 2024 //
PR NEWSWIRE
J&J Files For FDA Approval Of DARZALEX FASPRO Regimen
30 Sep 2024 //
PR NEWSWIRE
Venus Remedies Gets Approvals For Oncology Drugs In Two Countries
30 Sep 2024 //
PHARMABIZ
Darzalex SC Formulation Improves Negativity For Multiple Myeloma
27 Sep 2024 //
GLOBENEWSWIRE
Antengene To Commercialise XPOVIO In Thailand For Myeloma
23 Sep 2024 //
BIOSPECTRUM ASIA
Amneal and Shilpa Announce FDA Approval Of BORUZU, Ready-to-Use
05 Sep 2024 //
BUSINESSWIRE
Legend Biotech Reports Positive OS Results From CARTITUDE-4 Trial
02 Jul 2024 //
GLOBENEWSWIRE
DARZALEX Regimens Improved Outcomes In Newly Diagnosed MM
03 Jun 2024 //
GLOBENEWSWIRE
Sarclisa First Anti-CD38 To Improve PFS In Newly Diagnosed MM
03 Jun 2024 //
PRESS RELEASE
GSK details combo data that could bring Blenrep back to life
06 Feb 2024 //
FIERCE PHARMA
GSK`s blood cancer drug meets primary goal in late-stage trial
28 Nov 2023 //
REUTERS
Antengene Announces XPOVIO plus Bortezomib and Dexamethasone Included for Reimbursement by the PBS
31 May 2023 //
PR NEWSWIRE
MHRA Approves Selinexor Plus Bortezomib for Multiple Myeloma
22 Feb 2023 //
ONCLIVE
Karyopharm and Menarini Group Receive Full Marketing Authorization for NEXPOVIO
21 Feb 2023 //
PR NEWSWIRE
ScinoPharm Taiwan obtains Bortezomib for Injection ANDA approval
10 Feb 2023 //
PRESS RELEASE
Mylan`s Generic Bortezomib Receives Approval in the U.S.
31 Oct 2022 //
FDA
Waverley`s Generic Bortezomib Receives Approval in the U.S.
11 Oct 2022 //
FDA
EVER Pharma receives EU approval for liquid ready to use Bortezomib formulation
02 Sep 2022 //
PRESS RELEASE
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
29 Aug 2022 //
CLINICALTRIALSARENA
SMC approve Johnson & Johnson’s systemic light chain amyloidosis therapy
10 Aug 2022 //
PHARMA TIMES
SMC accepts first licensed treatment for newly diagnosed AL amyloidosis
09 Aug 2022 //
PHARMAFILE
Jiangsu Hansoh`s Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
Kindos Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
MSN Laboratories Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
Hospira, Inc. Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
Accord healthcare Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
Sandoz B2B`s Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
Dr. Reddy`s Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
Gland Pharma launches generic cancer treatment drug in US
04 May 2022 //
ECONOMIC TIMES
Eugia Pharma Generic Bortezomib Receives Approval in the U.S.
02 May 2022 //
FDA
Qilu Pharmaceutical Generic Bortezomib Receives Approval in the U.S.
02 May 2022 //
FDA
Fresenius Kabi USA Generic Bortezomib Receives Approval in the U.S.
02 May 2022 //
FDA
Apotex`s Generic Bortezomib Receives Approval in the U.S.
02 May 2022 //
FDA
Zydus Lifesciences gets USFDA`s nod to market generic version of Bortezomib
02 May 2022 //
ECONOMIC TIMES
Sandoz`s Generic Bortezomib Receives Approval in the U.S.
14 Mar 2022 //
FDA
Hospira`s Generic Bortezomib Receives Approval in the U.S.
10 Mar 2022 //
FDA
TGA Approves Antengene`s XPOVIO for r/r and TCR Multiple Myeloma
09 Mar 2022 //
PRNEWSWIRE
Enforcement Report - Week of March 02, 2022
02 Mar 2022 //
FDA
Troubled cancer center in Connecticut handed Form 483 by FDA, again
01 Feb 2022 //
ENDPTS
NICE recommends combination treatment for patients with multiple myeloma
24 Dec 2021 //
PHARMAFILE
Takeda previews early data for `Wave 2` multiple myeloma med
14 Dec 2021 //
FIERCEBIOTECH
ICR team identifies combination of five drugs for bone marrow cancer
13 Dec 2021 //
CLINICALTRIALSARENA
Sanofi`s Sarclisa, J&J`s Darzalex clash in 4-drug myeloma trials
11 Dec 2021 //
FIERCEPHARMA
Fresenius Kabi`s Generic Bortezomib Receives Tentative Approval in the U.S
14 Jul 2021 //
FDA
Janssen has Received European Marketing Authorizations for DARZALEX
22 Jun 2021 //
GLOBENEWSWIRE
Janssen seeksFDA approval for Darzalex Faspro to treat patients with amyloidosis
12 Sep 2020 //
PHARMABIZ
Janssen Submits Application Seeking U.S. FDA Approval of DARZALEX FASPRO
10 Sep 2020 //
BIOSPACE
EHA25Virtual: Study of Subcutaneous Daratumumab Shows Improved Clinical Outcomes
12 Jun 2020 //
PRNEWSWIRE
Karyopharm Reports Positive Phase 3 BOSTON Data in Oral Presentation at the ASCO
28 May 2020 //
GLOBENEWSWIRE
CHMP backs Sanofi’s myeloma drug Sarclisa
28 Mar 2020 //
PMLIVE
Hong Kong King-Friend Industrial Generic Bortezomib Receive Approval in U.S
24 Mar 2020 //
FDA
E.C Approves Darzalex, Bortezomib, Thalidomide and Dexamethasone combo
20 Jan 2020 //
BUSINESS WIRE
Eugia Pharma`s Generic Bortezomib Receive Approval in U.S
13 Jan 2020 //
FDA
Genmab`s Darzalex secures CHMP in Europe for front-line multiple myeloma
13 Dec 2019 //
PHARMAFILE
J&J`s Darzalex cuts death risk by 40% in new myeloma patients
09 Dec 2019 //
FIERCE PHARMA
Dr Reddy`s launches cancer treatment injection in US
04 Dec 2019 //
MONEY CONTROL
Hospira`s Generic Bortezomib Receives Approval in US
09 Nov 2019 //
FDA
J&J darzalex-FDA approval in frontline multiple myeloma use as Sanofi rival
28 Sep 2019 //
ENDPTS
